Cargando…
Corrigendum to: Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population‐based testing program
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253096/ https://www.ncbi.nlm.nih.gov/pubmed/34060208 http://dx.doi.org/10.1002/1878-0261.13018 |
Ejemplares similares
-
Tumor and germline next generation sequencing in high grade serous cancer: experience from a large population‐based testing program
por: Care, Melanie, et al.
Publicado: (2020) -
Corrigendum: Genetic testing in neurology exploiting next generation sequencing: state of art
Publicado: (2020) -
Corrigendum to “Optimized Next-Generation Sequencing Genotype-Haplotype
Calling for Genome Variability Analysis”
Publicado: (2022) -
Corrigendum to “Genetic Diagnosis of Charcot-Marie-Tooth Disease in a Population by Next-Generation Sequencing”
por: Høyer, Helle, et al.
Publicado: (2015) -
The Performance of Metagenomic Next-Generation Sequence in the Diagnosis of Suspected Opportunistic Infections in Patients with Acquired Immunodeficiency Syndrome [Corrigendum]
Publicado: (2023)